Question 1

What specific safety measures are in place for participants in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

Question 2

How does HRS-1738 compare to current imaging methods for prostate cancer?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the HRS-1738 injection?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients clinical trial (NCT07056439). Contact the study team or your healthcare provider for specific answers.

What this study is about